Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Enrique Martínez‐Pías"'
Autor:
Javier Trigo-López, Ángel Luis Guerrero-Peral, Álvaro Sierra, Enrique Martínez-Pías, María Gutiérrez-Sánchez, Elizabeth Huzzey, David García-Azorín
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background We aim to describe and compare patients and general practitioners’ opinions about the different variables related to acute and preventive treatment for migraine. Patients and methods An observational descriptive study was perfor
Externí odkaz:
https://doaj.org/article/aebaa827dd614d27939858fbdcab934b
Autor:
Carmen Sánchez-Rodríguez, Álvaro Sierra, Álvaro Planchuelo-Gómez, Enrique Martínez-Pías, Ángel L. Guerrero, David García-Azorín
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract To date, two randomized, controlled studies support the use of candesartan for migraine prophylaxis but with limited external validity. We aim to evaluate the effectiveness and tolerability of candesartan in clinical practice and to explore
Externí odkaz:
https://doaj.org/article/0edd85640e82420f91e4c08dc754ffef
Autor:
Priyank Khandelwal, Enrique Martínez-Pías, Ivo Bach, Tannavi Prakash, Machteld E Hillen, Mario Martínez-Galdámez, Juan F Arenillas
Publikováno v:
Brain Circulation, Vol 7, Iss 2, Pp 135-138 (2021)
Patients with COVID-19 may suffer from hemorrhagic complications. Our article highlights two cases of COVID-19-infected patients, who suffered severe epistaxis after initiation of intravenous recombinant tissue plasminogen activator (IV-rtPA) for acu
Externí odkaz:
https://doaj.org/article/acf288d5645140aabd8f71bcfbc28de5
Autor:
Javier Trigo, David García-Azorín, Álvaro Planchuelo-Gómez, Enrique Martínez-Pías, Blanca Talavera, Isabel Hernández-Pérez, Gonzalo Valle-Peñacoba, Paula Simón-Campo, Mercedes de Lera, Alba Chavarría-Miranda, Cristina López-Sanz, María Gutiérrez-Sánchez, Elena Martínez-Velasco, María Pedraza, Álvaro Sierra, Beatriz Gómez-Vicente, Juan Francisco Arenillas, Ángel L. Guerrero
Publikováno v:
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Introduction Headache is one of the most frequent neurologic manifestations in COVID-19. We aimed to analyze which symptoms and laboratory abnormalities were associated with the presence of headache and to evaluate if patients with headache
Externí odkaz:
https://doaj.org/article/ea176a0e8f6444a3b051496203f77951
Autor:
David García‐Azorín, Javier Trigo, Enrique Martínez‐Pías, Isabel Hernández‐Pérez, Gonzalo Valle‐Peñacoba, Blanca Talavera, Paula Simón‐Campo, Mercedes deLera, Alba Chavarría‐Miranda, Cristina López‐Sanz, María Gutiérrez‐Sánchez, Elena Martínez‐Velasco, María Pedraza, Álvaro Sierra, Beatriz Gómez‐Vicente, Ángel Guerrero, Juan Francisco Arenillas
Publikováno v:
Brain and Behavior, Vol 11, Iss 4, Pp n/a-n/a (2021)
Abstract Background Coronavirus disease 2019 (Covid‐19) might present neurological symptoms. We aimed to evaluate the frequency of them at the moment of emergency department (ED) visit and their impact in the prognosis. Methods Retrospective cohort
Externí odkaz:
https://doaj.org/article/0ce26c2bd05742149d3a8d8e96101cc2
Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients
Autor:
David García-Azorín, Enrique Martínez-Pías, Javier Trigo, Isabel Hernández-Pérez, Gonzalo Valle-Peñacoba, Blanca Talavera, Paula Simón-Campo, Mercedes de Lera, Alba Chavarría-Miranda, Cristina López-Sanz, María Gutiérrez-Sánchez, Elena Martínez-Velasco, María Pedraza, Álvaro Sierra, Beatriz Gómez-Vicente, Ángel Guerrero, David Ezpeleta, María Jesús Peñarrubia, Jose Ignacio Gómez-Herreras, Elena Bustamante-Munguira, Cristina Abad-Molina, Antonio Orduña-Domingo, Guadalupe Ruiz-Martin, María Isabel Jiménez-Cuenca, Santiago Juarros, Carlos del Pozo-Vegas, Carlos Dueñas-Gutierrez, Jose María Prieto de Paula, Belén Cantón-Álvarez, Jose Manuel Vicente, Juan Francisco Arenillas
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Introduction: Prognosis of Coronavirus disease 2019 (Covid-19) patients with vascular risk factors, and certain comorbidities is worse. The impact of chronic neurological disorders (CND) on prognosis is unclear. We evaluated if the presence of CND in
Externí odkaz:
https://doaj.org/article/b0159c5e0ff741fdba0165ced01c01a6
Publikováno v:
Toxins, Vol 13, Iss 6, p 432 (2021)
OnabotulinumtoxinA is one of the main preventive treatments for chronic migraine. Despite that up to one third of patients with chronic migraine suffer from daily headache, these individuals have hardly been studied. We conducted a prospective cohort
Externí odkaz:
https://doaj.org/article/33e9c6164c9641ad9f7cc25aee4a5fa2
Autor:
Ane Minguez-Olaondo, Ángel L Guerrero, M. Ruiz, Enrique Martínez-Pías, Álvaro Sierra, Javier Trigo, David García-Azorín
Publikováno v:
Expert Review of Neurotherapeutics. 21:123-130
Background: Triptanophobia is the excessive and inadequately justified concern about potential risks of triptans. We evaluated causes and consequences of nonuse of triptans in chronic migraine (CM) Methods: Case-control study. We included CM patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c73219efff9f9b4f70e6b8ba5b117d83
https://doi.org/10.1080/14737175.2021.1842733
https://doi.org/10.1080/14737175.2021.1842733
Autor:
Elizabeth Huzzey, María Gutiérrez-Sánchez, Álvaro Sierra, Javier Trigo-López, David García-Azorín, Enrique Martínez-Pías, Guerrero-Peral Ál
Publikováno v:
BMC Neurology
BMC Neurology, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Neurology, Vol 21, Iss 1, Pp 1-10 (2021)
Background We aim to describe and compare patients and general practitioners’ opinions about the different variables related to acute and preventive treatment for migraine. Patients and methods An observational descriptive study was performed. Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d48e301cf8698d76b3ebc7547e518dec
https://doi.org/10.1186/s12883-021-02220-w
https://doi.org/10.1186/s12883-021-02220-w
Publikováno v:
Cephalalgia. 39:1200-1203
Background Epicrania fugax is included in the appendix of the International Classification of Headache Disorders and is characterized as recurrent brief attacks of linear or zigzag pain moving across the cranial surface, commencing and terminating in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c726a36d1a603d894566efdb62345b9d
https://doi.org/10.1177/0333102419839793
https://doi.org/10.1177/0333102419839793